Demographics and baseline characteristics of the safety population. حسب Rahsan Erdem (11726357)

الموضوعات:

iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. حسب Rahsan Erdem (11726357)

الموضوعات:

Grading of stool consistency and diarrhea severity. حسب Rahsan Erdem (11726357)

الموضوعات:

Secondary efficacy endpoints for the modified intent-to-treat population. حسب Rahsan Erdem (11726357)

الموضوعات:

Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. حسب Rahsan Erdem (11726357)

الموضوعات:

Source data for Fig 1. حسب Rahsan Erdem (11726357)

الموضوعات:

Source data for S1 and S2 Figs. حسب Rahsan Erdem (11726357)

الموضوعات:

Source data for Fig 2. حسب Rahsan Erdem (11726357)

الموضوعات:

Consolidated Standards for Reporting of Trials flow diagram. حسب Rahsan Erdem (11726357)

الموضوعات:

iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. حسب Rahsan Erdem (11726357)

الموضوعات:

Source data for Fig 3. حسب Rahsan Erdem (11726357)

الموضوعات:

Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate. حسب Rahsan Erdem (11726357)

الموضوعات:

Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population. حسب Rahsan Erdem (11726357)

الموضوعات:

Diarrheal disease severity by treatment group for the modified intent-to-treat population. حسب Rahsan Erdem (11726357)

الموضوعات:

Maximum concentrations (ng/L) of 88 pharmaceuticals detected at least once (in order of decreasing number of detections across all regions and samples) in water samples from wadeab... حسب Paul M. Bradley (523469)

S1 Data - حسب Francois Kiemde (5369657)

"…Venous blood was collected at scheduled visit: Visit 1 (V1; 16–20 weeks of amenorrhea), Visit 2 (V2; 28 ±1 weeks of pregnancy), Visit 3 (V3; 32 ±1 weeks of pregnancy), Visit4 (V4; delivery) and Visit5 (V5; 6–7 weeks after delivery). …"

Characteristic of study population. حسب Francois Kiemde (5369657)

"…Venous blood was collected at scheduled visit: Visit 1 (V1; 16–20 weeks of amenorrhea), Visit 2 (V2; 28 ±1 weeks of pregnancy), Visit 3 (V3; 32 ±1 weeks of pregnancy), Visit4 (V4; delivery) and Visit5 (V5; 6–7 weeks after delivery). …"

Antibodies used for flow cytometry experiments. حسب Joseph Rabin (7399436)

الموضوعات:

Subject flow diagram. حسب Joseph Rabin (7399436)

الموضوعات:

Drugs IC₅₀s data during the study period. حسب Winnie Okore (14139712)

الموضوعات: